SCHINDLER
6.3.2019 20:03:11 CET | Business Wire | Press release
Today, Schindler announced the formation of BuildingMinds, a start-up created to optimize the management of real estate assets through a software-as-a-service platform.
Partnering with Microsoft, BuildingMinds is using Microsoft’s Azure and Dynamics 365 cloud platforms. Building owners will benefit from the combination of Microsoft’s intelligent cloud and business applications and Schindler’s domain knowledge in servicing real estate customers globally.
BuildingMinds will offer a one-stop service platform for real estate asset optimization, transforming the way buildings are managed in the real estate sector. The start-up will develop a fully integrated, product-agnostic, cloud solution that improves transparency and operational efficiency by allowing building owners to centrally manage all their properties and service providers.
Founded in Berlin, Europe’s prominent hub for property technology start-ups, BuildingMinds will serve customers worldwide and plans to grow its team to over 100 digital experts by year-end.
“Our partnership combines Schindler’s world-class expertise in the building management industry with the power of Microsoft technology to drive innovation across the sector. BuildingMinds will offer a range of smart building solutions, tailored to help building owners around the world facing daily operational challenges,” said Jean-Philippe Courtois, Executive Vice President and President, Microsoft Global Sales, Marketing and Operations.
“Today, properties use different supplier applications often unconnected with one another. As digitization advances, real estate owners face the challenge of managing the data locked in such an array of diverse applications within their portfolio of buildings,” said Jens Mueller, Chief Operating Officer of BuildingMinds.
“The demand for data-driven intelligence in building management and real estate asset optimization is significant and growing. Combining our industry insights with our digitization expertise will enable BuildingMinds to play a role in leading the change taking place in the sector,” said Silvio Napoli, Chairman of the Schindler Group. “This will close a long-standing gap in the advent of smart buildings, and we are pleased to be partnering with a global leader such as Microsoft on this pivotal initiative.”
Market research firm Orbis Research forecasts that the global smart-building market is expected to grow from around USD 8 billion in 2016 to around USD 58 billion by 2023. To tap into the opportunities of digitization, real estate companies are investing in new solutions that integrate their properties with their suppliers’ ecosystems and broader asset portfolio. By joining forces, BuildingMinds and Microsoft are bringing together the capabilities needed to accelerate this transformation.
BuildingMinds will operate as a stand-alone company within the Schindler Group. As its sole shareholder, Schindler has allocated funding of up to EUR 150 million to the start-up, a quarter of which it expects to expense in 2019.
About BuildingMinds
BuildingMinds enables the transformation of real estate into smart buildings, connecting real estate assets across the whole value chain through its fully integrated one-stop cloud platform. www.buildingminds.com
About Microsoft
Microsoft enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more. www.microsoft.com
About Schindler
Founded in Switzerland in 1874, the Schindler Group is a leading global provider of elevators, escalators, and related services. Schindler mobility solutions move more than one billion people every day all over the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005705/en/
Contact:
For further information: Nelly Keune, Chief Communications Officer Tel. +41 41 445 30 60, nelly.keune@schindler.com Marco Knuchel, Head of Investor Relations Tel. +41 41 445 30 61, marco.knuchel@schindler.com
Zugerstrasse 13 6030 Ebikon Switzerland
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom